Laurette Mhlanga

Sykes, W., Mhlanga, L., Swanevelder, R., Glatt, T.N., Grebe, E., Coleman, C., Pieterson, N., Cable, R., Welte, A., van den Berg, K. and Vermeulen, M., 2021. Prevalence of anti-SARS-CoV-2 antibodies among blood donors in Northern Cape, KwaZulu-Natal, Eastern Cape, and Free State provinces of South Africa in January 2021. Research Square.
Bingham, J., Cable, R., Coleman, C., Glatt, T.N., Grebe, E., Mhlanga, L., Nyano, C., Pieterson, N., Swanevelder, R., Swarts, A. and Sykes, W., 2022. Estimates of prevalence of anti-SARS-CoV-2 antibodies among blood donors in South Africa in March 2022. Research square.
Cable, R., Coleman, C., Glatt, T., Grebe, E., Mhlanga, L., Nyoni, C., Pieterson, N., Swanevelder, R., Swarts, A., Sykes, W. and van den Berg, K., 2022. Estimates of prevalence of anti-SARS-CoV-2 antibodies among blood donors in eight provinces of South Africa in November 2021. Research Square.
Vermeulen, M., Mhlanga, L., Sykes, W., Coleman, C., Pietersen, N., Cable, R., Swanevelder, R., Glatt, T.N., Grebe, E., Welte, A. and van den Berg, K., 2021. Prevalence of anti-SARS-CoV-2 antibodies among blood donors in South Africa during the period January-May 2021.
Iwu-Jaja, C., Ndlovu, N.L., Rachida, S., Yousif, M., Taukobong, S., Macheke, M., Mhlanga, L., van Schalkwyk, C., Pulliam, J., Moultrie, T. and le Roux, W., 2023. The role of wastewater-based epidemiology for SARS-CoV-2 in developing countries: cumulative evidence from South Africa supports sentinel site surveillance to guide public health decision-making. Science of The Total Environment, p.165817.
Mhlanga, L., Welte, A., Grebe, E., Ohler, L., Van Cutsem, G., Huerga, H. and Conan, N., 2023. Evidence of HIV incidence reduction in young women, but not in adolescent girls, in KwaZulu-Natal, South Africa. IJID Regions.
Mhlanga, L., Eduard, G. and Welte, A., 2021. Optimal accounting for age and time structure of HIV incidence estimates based on cross-sectional survey data with ascertainment of ‘recent infection’.